ガスクロマトグラフィシステムの世界市場：2025年～2032年

世界のガスクロマトグラフィシステムの市場規模は、2024年に36億6,875万米ドルに達し、2032年には72億359万米ドルに達すると予測され、予測期間の2025年～2032年のCAGRは8.8%になると見込まれています。

この成長の原動力は、クロマトグラフィ技術の進歩、各業界における用途の拡大、環境モニタリングや食品安全に関する政府の強力な規制です。製薬業界におけるガスクロマトグラフィ（GC）の応用で最も重要な分野の1つは、医薬品開発と品質管理手順です。インド・ブランド・エクイティ財団（IBEF）によると、インドの製薬セクターは変革が予想され、その規模は2024年までに約650億米ドル、2030年までに1,300億米ドルに増加し、さらに2047年までに4,500億米ドルに急増すると見込まれています。

現在、インドの製薬産業は500億米ドル規模であり、輸出だけで250億米ドル以上の貢献があると推定されています。このことは、医薬品製造工程における様々な健康関連規制を遵守するために、ガスクロマトグラフィのような高度な技術を採用する必要性を強調し、拡大の余地を与えています。現実に、これらの地域における環境および食品安全への懸念は、医療および製薬部門に加えて、北米および欧州市場におけるガスクロマトグラフィの開発および導入の取り組みに大きな影響を与えています。

さらに、これらの政府は、食品の安全性と環境汚染に関する懸念を解決するために、これらの方法を採用する必要性を認めています。たとえば、統合カナダの研究助成機関であるカナダイノベーション財団（CFI）は、ガスクロマトグラフィ質量分析（GC-MS）研究の促進など、必要なインフラの開発に約900万米ドルを投資しています。

当レポートでは、世界のガスクロマトグラフィシステム市場について調査し、市場の概要とともに、製品タイプ別、サンプルタイプ別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第5章 業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 持続可能性分析
• DMIオピニオン

第6章 製品タイプ別

• 機器
  • ガスクロマトグラフィ-質量分析法（GC-MS）
  • ガスクロマトグラフィ-水素炎イオン化検出法（GC-FID）
  • ガスクロマトグラフィ-電子捕獲検出器（GC-ECD）
  • ガスクロマトグラフィ-窒素リン検出器（GC-NPD）
  • その他
• アクセサリーと試薬

第7章 サンプルタイプ別

• ガス-液体クロマトグラフィ（GLC）
• ガス-固体クロマトグラフィ（GSC）

第8章 エンドユーザー別

• 製薬会社
• バイオテクノロジー企業
• 法医学部門
• 学術研究機関
• 食品・飲料業界
• 石油・ガス業界
• 環境試験機関
• その他

第9章 持続可能性分析

• 環境分析
• 経済分析
• ガバナンス分析

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他
• 中東・アフリカ

第11章 競合情勢

第12章 企業プロファイル

• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bruker Corporation
• PerkinElmer, Inc.
• Merck KGAA
• Shimadzu Corporation
• Waters Corporation
• Emerson Electric Co.
• SCION Instruments
• Danaher Corporation

第13章 付録

Global Gas Chromatography Systems Market reached US$ 3,668.75 million in 2024 and is expected to reach US$ 7,203.59 million by 2032, growing with a CAGR of 8.8% during the forecast period 2025-2032.

The growth is driven by advancements in chromatography technologies, increased applications across industries and strong governmental regulations for environmental monitoring and food safety. One of the most significant sectors for the application of gas chromatography (GC) in the pharmaceutical industry is drug development and quality control procedures. The pharmaceutical sector in India is expected to transform, with a size of approximately US$ 65 billion by 2024, increasing to US$ 130 billion by 2030 and then rapidly increasing to US$ 450 billion by 2047, according to the India Brand Equity Foundation (IBEF).

Currently, it is estimated that the Indian pharmaceutical industry is worth US$ 50 billion, with a contribution of over US$ 25 billion from exports alone. This underscores the necessity of employing sophisticated techniques, such as gas chromatography, to comply with a variety of health-related regulations during the drug manufacturing process, as it provides space for expansion. In reality, the environmental and food safety concerns in these regions have significantly impacted efforts to develop and implement gas chromatography in North America and European markets, in addition to the medical and pharmaceutical sectors.

Additionally, these governments have acknowledged the necessity of employing these methods to resolve concerns regarding food safety and environmental pollution. For example, the Canada Foundation for Innovation (CFI), the research funding body of Integrated Canada, has invested approximately $9 million in the development of the requisite infrastructure, which includes facilitating gas chromatography-mass spectrometry (GC-MS) research.

Dynamics

Significant Applications in Healthcare and Pharmaceutical Sector

Ongoing technological advancements and the formation of strategic collaborations within the industry. The diverse applications of GC systems are also a contributing factor to their growth. These applications encompass forensic sciences, environmental testing, pharmaceuticals, chemicals and food safety. The continuous influx of demand for the existing and developing economies markets is ensured by the diverse usability. The gas chromatography market is well-positioned for future growth, as it is characterized by sustainability and regulatory compliance, in addition to the introduction of new products.

It is anticipated that the gas chromatography system in pharmaceutical end-use will experience substantial growth during the forecast period. This segment was estimated to be worth US$ 982.47 Million in 2023 and is anticipated to experience a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031. The primary reason for the expansion of this market is the growing necessity for the implementation of effective analytical methods in the processes of regulatory drug registration, quality control and drug development.

Rising Regional and Global Collaborations

Governments worldwide have recognized the value of chromatography technologies in addressing challenges in healthcare, environmental sustainability and food safety. The Canadian government has invested in the Business Innovation Initiative, which supports companies like Natrix Separations in developing advanced single-use chromatography products for biopharmaceutical manufacturing.

The investments promote the commercialization of cutting-edge GC technologies, facilitating the development of precision instruments and increasing adoption. Similarly, The European Union actively funds collaborative research projects through programs like Horizon Europe, focusing on improving analytical instruments, including GC systems, to meet stringent environmental and food safety regulations.

Furthermore, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, The Environmental Protection Agency (EPA) works closely with GC manufacturers to enhance instruments used in air and water quality monitoring. This partnership ensures regulatory compliance while fostering innovation in instrument design.

High Dependency on Specialized Carrier Gases

The market for gas chromatography (GC) systems is primarily dependent on specialized carrier gases, such as helium. Helium is essentially indispensable in the operation of GCs due to its capacity for quality separation and non-reactivity. However, there is a global helium "crisis" that renders it significantly more expensive and difficult to obtain. The utilization of a biosystem was influenced by the rise in the cost and supply of helium. The US Department of Energy (DOE) has reported that GC has been rendered expensive and inaccessible for use in both medical and research applications.

Additionally, the global scarcity of helium necessitates the use of carrier gases, such as hydrogen or nitrogen, which are regarded as inferior. According to the National Institute of Standards and Technology (NIST), hydrogen is less expensive; however, it is also more flammable, which poses a risk. These complications increase the costs of operations and maintenance for laboratories and industries, necessitating the implementation of additional safety measures and facilities.

Segment Analysis

The global gas chromatography systems market is segmented based on product type, sample type, end-user and region.

Adoption of Advanced Detectors Fuels the Demand of Gas Chromatography Systems Instruments

The instruments segment is poised for steady growth, driven by technological advancements, regulatory requirements and increasing demand across sectors including pharmaceuticals, food safety and environmental monitoring. Key factors include the adoption of advanced detectors, integration with automation software and the miniaturization of portable units.

For instance, in May 2024, Agilent Technologies launched the 8850 Gas Chromatograph (GC) System, a compact single-channel GC that blends the legacy of the 6850 GC with the advanced capabilities of the 8890 GC. Designed for efficiency and intelligence, the 8850 GC is tailored to meet the needs of modern labs in energy, chemicals, food and pharmaceuticals, offering up to 30% reduced energy consumption. It addresses key challenges such as maximizing productivity within limited bench space and aligning operations with sustainability goals by enhancing instrument uptime and operational efficiency.

Geographical Penetration

Rising Demand for Accurate Chemical Analysis in North America

North America gas chromatography market is witnessing consistent expansion, primarily fueled by innovations in analytical methodologies and a rising demand for accurate chemical analysis across various sectors. Critical areas including medicines, environmental monitoring, food and drinks and chemicals are driving the increasing demand for gas chromatography equipment. Technological developments, including miniaturization, automation and the integration of artificial intelligence (AI) for data processing, are boosting the capabilities and efficiency of gas chromatography systems, further expanding their market presence.

Gas chromatography has found significant application in the oil and gas industry, where it plays a key role in assuring the quality and uniformity of chemical analysis. In recent years, North America's total crude oil output attained 46,233,753 Terajoules (TJ), reflecting a 66% increase from 2000, as reported by the International Energy Agency (IEA). The rise of the oil and gas sector is directly fostering the growth of the gas chromatography market, as these systems are essential for analyzing the composition of hydrocarbons and other gases.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bruker Corporation, PerkinElmer, Inc., Merck KGAA, Shimadzu Corporation, Waters Corporation, Emerson Electric Co., SCION Instruments and Danaher Corporation.

Sustainable Analysis

Gas chromatography plays a crucial role in environmental sustainability by ensuring the precise identification and quantification of contaminants. Its accuracy and versatility render it essential for assessing ecological well-being and adhering to changing requirements These cutting-edge instruments address evolving industry needs across pharmaceuticals, food safety and environmental monitoring. With a focus on productivity and sustainability, the market is poised for sustained growth across diverse applications.

The demand for gas chromatography is especially prominent in areas prioritizing healthcare improvements. The National Cancer Center of Japan estimated more than 1 million new cancer cases in 2022, highlighting the increasing demand for accurate analytical methods in oncology research. In Saudi Arabia, the Vision 2030 project has catalyzed investments in healthcare, biotechnology and environmental sustainability.

Recent Developments

• In October 2024, Bruker BioSpin Group has announced the acquisition of Bridge12's Electron Paramagnetic Resonance (EPR) business. This acquisition enhances Bruker's suite of EPR spectroscopy offerings, including Bridge12's modular EPR bridges for pulsed spectroscopy, high-field EPR spectrometers for multi-frequency experiments, microwave amplifiers and EPR probes. The addition of Bridge12's innovative technology, including its compact Q-Band EPR resonator for small sample analysis, strengthens Bruker's position in the research industry.
• In June 2024, Agilent Technologies Inc. has introduced the Agilent 7010D Triple Quadrupole GC/MS System (7010D GC/TQ). To target the food and environmental markets, the 7010D GC/TQ features the new HES 2.0 ion source, offering attogram-level sensitivity, advanced built-in intelligence and environmentally conscious design with the My Green Lab ACT Label. Paired with the MassHunter Acquisition 13.0 software, the system enhances data integrity and compliance, reflecting Agilent's commitment to precision and sustainability.
• In December 2023, PerkinElmer Inc. has announced its acquisition of Covaris, to create an innovation-driven global life sciences and diagnostics platform. This strategic move will accelerate Covaris' growth potential and broaden PerkinElmer's portfolio, particularly in the rapidly expanding diagnostics market. The merger strengthens PerkinElmer's position in genomics, transcriptomics and proteomics, offering significant growth opportunities in diagnostics, biopharma and clinical research globally.

By Product Type

• Instrument
  • Gas Chromatography-Mass Spectrometry (GC-MS)
  • Gas Chromatography-Flame Ionization Detection (GC-FID)
  • Gas Chromatography-Electron Capture Detection (GC-ECD)
  • Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
  • Others
• Accessories & Reagents

By Sample Type

• Gas-Liquid Chromatography (GLC)
• Gas-Solid Chromatography (GSC)

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Forensic Departments
• Academic and Research Institutes
• F&B Industries
• Oil & Gas Industries
• Environmental Testing Agencies
• Others

By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?

• To visualize the global gas chromatography systems market segmentation based on product type, sample type, end-user, & region.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points at the gas chromatography systems market level for all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gas chromatography systems market report would provide approximately 62 tables, 55 figures and 205 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Sample Type
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Significant Applications in Healthcare and Pharmaceutical Sector
    • 4.1.1.2. Rising Regional and Global Collaborations
  • 4.1.2. Restraints
    • 4.1.2.1. High Dependency on Specialized Carrier Gases
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Sustainable Analysis
• 5.6. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Instruments*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.2.1. Gas Chromatography-Mass Spectrometry (GC-MS)
    • 6.2.2.2. Gas Chromatography-Flame Ionization Detection (GC-FID)
    • 6.2.2.3. Gas Chromatography-Electron Capture Detection (GC-ECD)
    • 6.2.2.4. Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
    • 6.2.2.5. Others
• 6.3. Accessories & Reagents

7. By Sample Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 7.1.2. Market Attractiveness Index, By Sample Type
• 7.2. Gas-Liquid Chromatography (GLC)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Gas-Solid Chromatography (GSC)

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Pharmaceutical Companies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Biotechnology Companies
• 8.4. Forensic Departments
• 8.5. Academic and Research Institutes
• 8.6. F&B Industries
• 8.7. Oil & Gas Industries
• 8.8. Environmental Testing Agencies
• 8.9. Others

9. Sustainability Analysis

• 9.1. Environmental Analysis
• 9.2. Economic Analysis
• 9.3. Governance Analysis

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. US
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Key Region-Specific Dynamics
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Thermo Fisher Scientific Inc.*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Agilent Technologies Inc.
• 12.3. Bruker Corporation
• 12.4. PerkinElmer, Inc.
• 12.5. Merck KGAA
• 12.6. Shimadzu Corporation
• 12.7. Waters Corporation
• 12.8. Emerson Electric Co.
• 12.9. SCION Instruments
• 12.10. Danaher Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us